These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31711833)

  • 21. Cryoablation of renal fossa recurrence after radical nephrectomy.
    Suson KD; Richard H; Phelan MW
    J Endourol; 2011 Apr; 25(4):559-62. PubMed ID: 21381955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol.
    Antonelli A; Cozzoli A; Zani D; Zanotelli T; Nicolai M; Cunico SC; Simeone C
    BJU Int; 2007 Feb; 99(2):296-300. PubMed ID: 17326263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
    Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
    BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
    Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathologic features and prognostic analyses of locally recurrent renal cell carcinoma patients after initial surgery].
    Tang Q; Lin RC; Yao L; Zhang Z; Hao H; Zhang CJ; Cai L; Li XS; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):628-631. PubMed ID: 31420612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy.
    Staník M; Poprach A; Littnerová S; Čapák I; Hulová M; Šebová N; Lakomý R; Jarkovský J; Doležel J
    Urol Oncol; 2022 Mar; 40(3):111.e27-111.e34. PubMed ID: 34961683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma.
    Iimura Y; Kihara K; Saito K; Masuda H; Kobayashi T; Kawakami S
    Int J Urol; 2008 Jan; 15(1):44-7. PubMed ID: 18184170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center.
    Andrade HS; Zargar H; Akca O; Kara O; Caputo PA; Ramirez D; Andrés G; Stein RJ; Chueh SJ; Kaouk JH
    J Endourol; 2017 Feb; 31(2):153-157. PubMed ID: 27881027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection.
    Karellas ME; Jang TL; Kagiwada MA; Kinnaman MD; Jarnagin WR; Russo P
    BJU Int; 2009 Jan; 103(2):160-4. PubMed ID: 18782305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
    Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma.
    Zhang ZL; Li YH; Xiong YH; Hou GL; Yao K; Dong P; Liu ZW; Han H; Qin ZK; Zhou FJ
    Chin J Cancer; 2010 Dec; 29(12):995-9. PubMed ID: 21114919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series.
    van der Mijn JC; Al Hussein Al Awamlh B; Islam Khan A; Posada-Calderon L; Oromendia C; Fainberg J; Alshak M; Elahjji R; Pierce H; Taylor B; Gudas LJ; Nanus DM; Molina AM; Del Pizzo J; Scherr DS
    PLoS One; 2019; 14(12):e0226285. PubMed ID: 31815952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes.
    Ray S; Cheaib JG; Biles MJ; Pineault KG; Johnson MH; Ged YMA; Markowski MC; Singla N; Allaf ME; Pierorazio PM
    Urology; 2021 Aug; 154():201-207. PubMed ID: 33864855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
    Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
    Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
    Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution.
    Takagi T; Yoshida K; Wada A; Kondo T; Fukuda H; Ishihara H; Kobayashi H; Iizuka J; Okumi M; Ishida H; Nagashima Y; Tanabe K
    Int J Clin Oncol; 2020 May; 25(5):892-898. PubMed ID: 32048086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
    Blute M; Thibault GP; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2003 Sep; 170(3):760-3. PubMed ID: 12913692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding?
    Rouach Y; Delongchamps N; Timsit MO; Verkarre V; Fontaine E; Peyromaure M; Mejean A
    BJU Int; 2010 Mar; 105(5):616-9. PubMed ID: 19681891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.